Endodiag

The company develops non-invasive diagnostic solutions for endometriosis, specifically focusing on a blood test based on disease-specific biomarkers to replace surgical diagnosis. They provide tools for healthcare professionals to map the disease for personalized patient management and partner with pharmaceutical teams to support the development of new targeted therapies. Their products aim to reduce diagnostic delays and assist in fertility strategy and treatment assessment.